Table 2 Comparison between hyperbilirubinemic neonates and controls in full-term neonates before and after phototherapy
From: Role of phototherapy, BAX gene expression in hyperbilirubinemia development in full-term neonates
Full-term | p value | ||
|---|---|---|---|
Cases | Control | ||
N = 18 | N = 9 | ||
T.B. (mg/dl) pre | |||
Range | 7.6–26.1 | 0.7–2 | < 0.001* |
Mean ± SD | 19.6 ± 4.7 | 1.4 ± 0.5 | |
T.B. (mg/dl) post | |||
Range | 5.1–20.6 | 0.7–2 | < 0.001* |
Mean ± SD | 14.1 ± 4.3 | 1.4 ± 0.5 | |
D.B. (mg/dl) pre | |||
Range | 0.5–4.7 | 0.1–0.5 | < 0.001* |
Mean ± SD | 1.3 ± 0.9 | 0.3 ± 0.2 | |
Median | 1.2 | 0.3 | |
D.B. (mg/dl) post | |||
Range | 0.3–8.7 | 0.1–0.5 | < 0.001* |
Mean ± SD | 1.6 ± 1.8 | 0.3 ± 0.2 | |
Median | 1.2 | 0.3 | |
BCL2 pre | |||
Range | 206–657 | 409–588 | 0.310 |
Mean ± SD | 451.2 ± 132.6 | 499.8 ± 61.8 | |
BCL2 post | |||
Range | 91–572 | 409–588 | 0.001* |
Mean ± SD | 315.3 ± 134.1 | 499.8 ± 61.8 | |
BAX pre | |||
Range | 28–70 | 28–62 | 0.461 |
Mean ± SD | 49.7 ± 11 | 46.3 ± 10.7 | |
Median | 48 | ||
BAX post | |||
Range | 58–96 | 28–62 | < 0.001* |
Mean ± SD | 76.3 ± 9.6 | 46.3 ± 10.7 | |
Median | 48 | ||